Evidence that TLR4 is not a receptor for saturated fatty acids but mediates lipid-induced inflammation by reprogramming macrophage metabolism
- Author(s)
- Lancaster, GI; Langley, KG; Berglund, NA; Kammoun, HL; Reibe, S; Estevez, E; Weir, J; Mellett, NA; Pernes, G; Conway, JRW; Lee, MKS; Timpson, P; Murphy, AJ; Masters, SL; Gerondakis, S; Bartonicek, N; Kaczorowski, DC; Dinger, ME; Meikle, PJ; Bond, PJ; Febbraio, MA;
- Details
- Publication Year 2018-05-01,Volume 27,Issue #5,Page 1096-1110 e5
- Journal Title
- Cell Metabolism
- Publication Type
- Journal Article
- Abstract
- Chronic inflammation is a hallmark of obesity and is linked to the development of numerous diseases. The activation of toll-like receptor 4 (TLR4) by long-chain saturated fatty acids (lcSFAs) is an important process in understanding how obesity initiates inflammation. While experimental evidence supports an important role for TLR4 in obesity-induced inflammation in vivo, via a mechanism thought to involve direct binding to and activation of TLR4 by lcSFAs, several lines of evidence argue against lcSFAs being direct TLR4 agonists. Using multiple orthogonal approaches, we herein provide evidence that while loss-of-function models confirm that TLR4 does, indeed, regulate lcSFA-induced inflammation, TLR4 is not a receptor for lcSFAs. Rather, we show that TLR4-dependent priming alters cellular metabolism, gene expression, lipid metabolic pathways, and membrane lipid composition, changes that are necessary for lcSFA-induced inflammation. These results reconcile previous discordant observations and challenge the prevailing view of TLR4's role in initiating obesity-induced inflammation.
- Publisher
- Cell Press
- Research Division(s)
- Inflammation
- PubMed ID
- 29681442
- Publisher's Version
- https://doi.org/10.1016/j.cmet.2018.03.014
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2018-05-18 09:33:19
Last Modified: 2018-06-27 09:45:07